Tirzepatide (B6/B12)
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
Back to peptide library
Dual incretin weight management
Tirzepatide
A clinician-guided dual GIP/GLP-1 option used in weight-management programs to support appetite regulation, satiety, glucose-related goals, and long-term metabolic strategy.
GIP + GLP-1 activity Weekly injectable options Oral tablet options listed MD eligibility review
Overview
What is tirzepatide?
Tirzepatide is a dual incretin medication that activates GIP and GLP-1 receptor pathways. These hormone pathways are involved in appetite, fullness, insulin response, glucose regulation, and metabolic signaling.
IPS frames tirzepatide as one tool inside a broader performance and metabolic-health plan. The goal is not only weight change, but better structure around nutrition, strength training, lean-mass protection, recovery, and maintenance.
Common program goals
- Reduce appetite and food noise
- Support clinically guided body-composition change
- Improve adherence to nutrition targets
- Support glucose and metabolic-health markers
- Build a maintenance plan for after active weight loss
IPS access
Available tirzepatide listings.
These entries come from the IPS access available list. Final formulation, titration approach, and route depend on consultation, eligibility, availability, and clinician judgment.
Tirzepatide (B6/B12)
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
Tirzepatide (B6/B12)
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
Tirzepatide (B6/B12)
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
Tirzepatide (B6/B12)
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
Tirzepatide (B6/B12)
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
Tirzepatide tablets
Tablet listings include , , , and options.
Mechanism
How tirzepatide may support weight management.
Tirzepatide works through two incretin pathways. This dual action is why patients often ask about it when appetite, metabolic health, and more intensive body-composition goals are part of the conversation.
GIP receptor activity
GIP signaling is involved in insulin response and metabolic regulation, and may complement GLP-1 activity.
GLP-1 receptor activity
GLP-1 pathways can influence appetite, satiety, gastric emptying, and glucose-dependent insulin signaling.
Metabolic support
Dual incretin therapy may be discussed when weight management and glucose-related goals overlap.
Maintenance planning
IPS pairs medication discussions with nutrition structure, protein targets, resistance training, and follow-up.
Process
How tirzepatide care works at IPS.
Consultation
Review goals, weight history, medications, contraindications, training, nutrition, and prior GLP-1 or incretin experience.
Baseline Review
Labs and history help determine whether tirzepatide is reasonable and what monitoring is appropriate.
Titration Plan
If appropriate, protocols are adjusted gradually to balance response, side effects, nutrition intake, and clinical goals.
Ongoing Support
Follow-up focuses on progress, tolerance, hydration, protein intake, lean-mass protection, and maintenance strategy.
Safety & candidacy
Tirzepatide requires medical screening.
Eligibility depends on a clinician review. IPS screens for relevant medical history, current medications, pregnancy or breastfeeding status where applicable, prior side effects, and risk factors before discussing treatment.
Common effectsNausea, constipation, diarrhea, vomiting, reflux, and appetite changes can occur, especially during protocol changes.
ScreeningPatients with certain thyroid cancer histories, MEN2 history, pancreatitis risk, gallbladder concerns, or pregnancy-related factors need careful review.
MonitoringFollow-up helps evaluate tolerance, hydration, nutrition intake, weight trend, and whether the protocol should change.
No guaranteesResults vary and depend on adherence, tolerance, nutrition, activity, sleep, and individual response.
Questions
Frequently asked.
How is tirzepatide different from semaglutide?
Semaglutide works primarily through GLP-1 receptor activity. Tirzepatide works through both GIP and GLP-1 pathways. Which option is appropriate depends on medical history, goals, tolerance, and clinician judgment.
How often is it usually taken?
Injectable tirzepatide protocols are commonly weekly, but route and schedule must be prescribed based on the actual formulation and patient context.
Does IPS list both injectable and oral options?
Yes. The current available list includes tirzepatide B6/B12 injectable listings and oral tirzepatide tablet listings. Availability and suitability still require consultation.
Will I need a maintenance plan?
Yes. IPS treats maintenance as part of the program, with attention to protein, resistance training, sleep, habits, and follow-up after active weight-loss phases.
Contact
Ask IPS about tirzepatide eligibility.
Complete the form and IPS will follow up about consultation scheduling and next steps.
Medical note This page is educational and is not intended to diagnose, treat, cure, or prevent disease. Medication decisions require consultation with a qualified clinician.